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Abstract
Background: The SD FK80 P.f/P.v Malaria Antigen Rapid Test (Standard Diagnostics, Korea)
(FK80) is a three-band malaria rapid diagnostic test detecting Plasmodium falciparum histidine-rich
protein-2 (HRP-2) and Plasmodium vivax-specific lactate dehydrogenase (Pv-pLDH). The present
study assessed its performance in a non-endemic setting.
Methods: Stored blood samples (n = 416) from international travellers suspected of malaria were
used, with microscopy corrected by PCR as the reference method. Samples infected by Plasmodium
falciparum (n = 178), Plasmodium vivax (n = 99), Plasmodium ovale (n = 75) and Plasmodium malariae
(n = 24) were included, as well as 40 malaria negative samples.
Results: Overall sensitivities for the diagnosis of P. falciparum and P. vivax were 91.6% (95%
confidence interval (CI): 86.2% - 95.0%) and 75.8% (65.9% - 83.6%). For P. falciparum, sensitivity at
parasite densities ≥ 100/μl was 94.6% (88.8% - 97.6%); for P. vivax, sensitivity at parasite densities ≥
500/μl was 86.8% (75.4% - 93.4%). Four P. falciparum samples showed a Pv-pLDH line, three of them
had parasite densities exceeding 50.000/μl. Two P. vivax samples, one P. ovale and one P. malariae
sample showed a HRP-2 line. For the HRP-2 and Pv-pLDH lines, respectively 81.4% (136/167) and
55.8% (43/77) of the true positive results were read as medium or strong line intensities. The FK80
showed good reproducibility and reliability for test results and line intensities (kappa values for
both exceeding 0.80).
Conclusion:  The FK80 test performed satisfactorily in diagnosing P. falciparum and  P. vivax
infections in a non-endemic setting.
Background
Malaria rapid diagnostic tests (RDTs) are immunochro-
matographic tests that detect circulating antigens of Plas-
modium species. They are an adjunct to the microscopic
diagnosis of malaria, both in the endemic and in the non-
endemic settings [1-5]. RDTs are built on a nitrocellulose
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platform and are available in dipstick or cassette format.
Signals are visible as coloured lines, comprising a control
line (which indicates that the test has been performed
well) and one or two test lines. The so-called two band
tests generate a test line that targets P. falciparum by detect-
ing either histidine-rich protein 2 (HRP-2) or P. falci-
parum-specific parasite lactate dehydrogenase (Pf-pLDH).
The three band tests include a second target that is com-
mon to the four Plasmodium species, such as aldolase or
pan-specific parasite lactate dehydrogenase (pan-pLDH).
Apart from these common formats, there are also two-
band tests detecting Plasmodium vivax-specific pLDH (Pv-
pLDH) [6]. The SD FK80 P.f/P.v Malaria Antigen Rapid
Test (Standard Diagnostics, Hagal-Dong, Republic of
Korea), further referred to as FK80, is a three-band RDT
that targets HRP-2 and Pv-pLDH. In areas where both P.
falciparum and P. vivax are prevalent, this combination has
the advantage to distinguish unequivocally between the
two species, whereas a conventional three band P. falci-
parum/Pan species RDT may not. For instance, in case of a
single P. falciparum infection, the FK80 P.f/P.v Malaria
Antigen Rapid Test will only show a unique HRP-2 line; in
this case the conventional three band P. falciparum/Pan
species RDT may show (depending on the parasite den-
sity) both the HRP-2 (or Pf-pLDH line) and the pan-spe-
cies line, a result which is also compatible with a P.
falciparum/P. vivax mixed infection. In addition, it can be
assumed that the affinity of a dedicated antibody targeting
the enzyme of only a single species (Pv-pLDH in the case
of P. vivax and the current FK80 RDT) is higher than the
affinity of an antibody targeting the different enzymes of
the four Plasmodium species (pan-pLDH). The aim of the
study was to evaluate the performance of the FK80 in a
non-endemic reference setting.
Methods
Study design
In this retrospective study, the FK80 was evaluated against
a collection of stored samples obtained from interna-
tional travellers, collected from January 1997 to Decem-
ber 2008. Tests were carried out at the malaria reference
laboratory of the Institute of Tropical Medicine (ITM) Ant-
werp, Belgium. This study complied with the standards for
the reporting of diagnostic accuracy studies (STARD) [7].
Patients and samples
Samples were selected from a collection of EDTA-blood
samples stored at -70°C and obtained from patients pre-
senting at the outpatient clinic of ITM for clinical suspi-
cion of malaria. The patients were international travellers
and, to a lesser extent, immigrants returning from visits to
their native countries. In addition, samples sent by Bel-
gian laboratories to ITM in the scope of the national refer-
ence function were included. The samples collected at
ITM, were aliquoted and frozen at -70°C the day of collec-
tion. Between collection and storage at -70°C, the sam-
ples remained at room temperature for a maximum of 10
hours, at ambient temperatures below 25°C. The 99 sam-
ples sent by Belgian laboratories to ITM for second opin-
ion and confirmation were sent by mail and had been
exposed to ambient temperature for the period of ship-
ment, which was generally less than 24 hours and ranged
to a maximum of 48 hours. The delays of shipment and
processing before storage at -70°C had been validated
before and were compliant with routine laboratory proce-
dures. A representative number of Plasmodium-positive
samples (n = 376) were selected, including the four
malaria species with varying parasite densities and repre-
sentative geographic distribution. Mixed infections were
not included. In addition, samples without malaria para-
sites (as confirmed by microscopy and PCR) from symp-
tomatic travellers suspected of malaria were included
(negative samples, n = 40).
Reference method
Microscopy corrected by polymerase chain reaction (PCR)
was used as the reference method. Standard microscopy
was performed on thick blood films of all samples to diag-
nose malaria and to assess parasite density, and on thin
blood films of positive samples to define the Plasmodium
species. Thick blood films were stained with Giemsa (pH
= 8) for 20 minutes, thin films with May-Grünwald
Giemsa. The slides were examined by light microscopy
using a × 500 magnification, according to the standard
procedure at ITM. Parasite density was assessed by count-
ing the number of asexual parasites against 200 white
blood cells in a thick film, and converting the value to par-
asites/μl using the actual count or the standard of 8,000
white blood cell/μl [3]. Malaria diagnosis at Central Lab-
oratory of Clinical Biology is accredited in accordance
with the requirements of the ISO 15189:2007 norm. The
laboratory technicians have received a detailed training
and their performance and agreement are monitored by
participation to internal and external quality control
assessments. As a standard procedure, all positive slides
for malaria and slides showing discordant results between
different laboratory tests (microscopy, RDTs or PCR) are
confirmed by a blinded second microscopist. Real-time
PCR analysis was adapted from Rougemont et al [8] as
described previously [9] and performed on all samples
used in this study.
Test platform
The FK80 is lateral flow immunochromatographic RDT in
a cassette format. Three lines are present, a control line
which indicates whether the test is valid, a HRP-2 line and
a Pv-pLDH line. According to the manufacturer's instruc-
tions, a single HRP-2 line indicates an infection with P.
falciparum, a single Pv-pLDH line indicates an infection
with P. vivax and a combination of a HRP-2 line and a Pv-Malaria Journal 2009, 8:262 http://www.malariajournal.com/content/8/1/262
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pLDH line indicates a mixed infection with P. falciparum
and  P. vivax. The other Plasmodium  species cannot be
detected with this test. For the evaluation, test kits of lot
number RDT 8002 (expiry date November 2010) were
used.
Test procedure
Tests were according to the instructions of the manufac-
turer except that samples (5 μl) where loaded with a trans-
fer pipette (Finnpipette, Helsinki, Finland) instead of the
plastic loop supplied by the manufacturer and that a scor-
ing system was used to assess the intensity of the test lines.
In case the control line did not appear, the result was
interpreted as invalid and the test was repeated. In order
to score test line intensities, the scoring system of Bell and
co-workers was adapted [10] and five categories were
defined: none (no line visible), faint (barely visible line),
weak (paler than the control line), medium (equal to the
control line) or strong (stronger than the control line) [9].
To assure timely readings, tests were carried out in time-
controlled batches of ten samples. Readings were carried
out at daylight assisted by a standard electricity bulb,
between 20 and not beyond 30 minutes after application
of the sample and buffer. Readings were performed by
three subsequent observers, of whom the one who per-
formed the test procedure was the first. Observers were
blinded to the results of microscopy, PCR and to each oth-
ers' readings. The results of the readings considered were
based on consensus agreement, which means that a posi-
tive result was defined as a result read positive by at least
two out of three different observers. When there was no
consensus, results of the first observer were considered.
Inter-reader reliabilities were assessed for the test results
expressed as positive and negative readings as well as for
the intensity readings. To assess test reproducibility, a
panel of 19 samples (including nine P. falciparum sam-
ples, eight P. vivax samples, one P. ovale sample and one
P. malariae sample) was tested on three successive occa-
sions.
Definitions
Samples infected with P. falciparum and P. vivax species
were considered separately: Tables 1 and 2 list the defini-
tions of true positive and negatives and those of species
mismatches. In the case of P. falciparum, samples with
pure gametocytaemia were included among the positive
samples.
Statistical analysis
Sensitivity and specificity were calculated for both P. falci-
parum and P. vivax with 95% confidence intervals (CI) and
differences were tested for significance using the Pearson
chi-square test or, when this was not possible, the Fisher
exact probability test. A p-value of < 0.05 was considered
as significant. Reliabilities for positive and negative read-
ings and line intensities were calculated as percentage
agreements for all three readers and kappa values for each
pair of readers. Associations between line intensity read-
ings and parasite densities were assessed for strength of
association with Cramer's V for categorical variables.
Ease of use
Three experienced laboratory technicians scored the ease
of use of the FK80 test and the clarity of manufacturer's
instructions with a standardized list.
Ethical review
The study was reviewed and approved by the Institutional
Review Board of ITM and by the Ethical Committee of
Antwerp University, Belgium.
Results
Sample collection
A total of 416 samples were selected, of which 99 samples
were sent by Belgian laboratories to ITM for second opin-
ion and confirmation. The samples were collected from
January 1997 to December 2008. They were obtained in
416 patients, with a male-to-female ration of 2.19:1, and
median age of 38.5 years (range 1 - 84 years). Only a
minority (eight patients, 1.9%) were children less than
five years old.
Table 1: Interpretation of test results of the FK80 for the detection of P. falciparum
Test Line(s) visible Species identification by microscopy corrected by PCR
P. falciparum P. vivax, P. ovale, P. malariae
or no parasites detected
Only HRP-2 True positive False positive
or
species-mismatch*
None or
only Pv-pLDH or
HRP-2 + Pv-pLDH
False negative
or
species-mismatch**
True negative
*Non-falciparum species diagnosed as P. falciparum
**P. falciparum diagnosed as P. vivax or as P. falciparum/P. vivax mixed infectionMalaria Journal 2009, 8:262 http://www.malariajournal.com/content/8/1/262
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According to microscopy and after correction with PCR
analysis, 178 of these samples were positive for P. falci-
parum, 99 for P. vivax, 75 for P. ovale and 24 for P. malar-
iae. The results of microscopy were corrected in 11 out of
the 376 positive samples (2.9%) and were uniquely
related to P. vivax - P. ovale mismatches: in the final collec-
tion, four out of 99 (4.0%) P. vivax samples and seven out
of 74 (9.5%) P. ovale samples had been identified as P.
ovale and P. vivax by microscopy. In addition, 40 micro-
scopic and PCR negative samples of symptomatic travel-
lers were included in the panel.
Invalid test results
One of the 416 samples gave an invalid result at initial
testing. After 30 minutes, there was no control line visible.
Upon repetition, the test performed well.
Sensitivity and specificity
RDTs were performed between January and February
2009. Table 3 lists the test results of all samples. Test char-
acteristics matched with species identification and para-
site density for the detection of P. falciparum and P. vivax
are listed in tables 4 and 5 respectively. For the detection
of P. falciparum the sensitivity was 91.6% and the specifi-
city was 99.2% for all samples combined. Sensitivity was
higher at higher parasite densities, but the differences did
not reach statistical significance. For the detection of P.
vivax  the sensitivity was 75.8% and the specificity was
100% for all samples combined. Sensitivity at parasite
densities ≤ 500/μl was significantly lower compared to
sensitivity at parasite densities >500/μl (51.6% and
86.8% respectively (p < 0.001)). Eight out of the 416 sam-
ples resulted in a species mismatch, with 4/178 (2.2%) P.
falciparum samples showing a Pv-pLDH line in addition to
the HRP-2 line: three of them had parasite densities
higher than 1% (69,953; 87,149 and 1,000,000/μl respec-
tively) and all four patients were upon return from Africa
(travel destination were Nigeria (n = 3) and Cameroon).
Another four out of 199 (2.0%) non-falciparum samples
showed a HRP-2 line (of which two P. vivax samples in
addition to the Pv-pLDH line) (Table 3). None of the P.
ovale samples showed positive readings with the Pv-pLDH
line.
Line intensities
For the HRP-2 and Pv-pLDH lines, respectively 81.4%
(136/167) and 55.8% (43/77) of the true positive results
were read as medium or strong line intensities. For HRP-
2, faint lines occurred only in three samples: one P. falci-
parum sample with pure gametocytaemia and two non-fal-
ciparum samples. For Pv-pLDH, faint lines occurred only
in eight samples: six P. vivax samples (four of them with a
parasitemia lower than 500 parasites/μl) and two P. falci-
parum samples. Line intensity readings for both HRP-2
Table 2: Interpretation of test results of the FK80 for the detection of P. vivax
Test Line(s) visible Species identification by microscopy corrected by PCR
P. vivax P. falciparum, P. ovale, P. malariae or no parasites detected
Only Pv-pLDH True positive False positive
or
species-mismatch*
None or
only HRP-2 or
both HRP-2 and Pv-pLDH
False negative
or
species-mismatch**
True negative
*Non-vivax species diagnosed as P. vivax
**P. vivax diagnosed as P. falciparum or as P. falciparum/P. vivax mixed infection
Table 3: Test results for the FK80 for all samples (n = 416)
Sample HRP-2 line positive HRP-2 line negative Total
Pv-pLDH line positive Pv-pLDH line negative Pv-pLDH line positive Pv-pLDH line negative
P. falciparum 4* 163 11 178
P. vivax 2* 75 22° 99
P. ovale 1* 74 75
P. malariae 1* 23 24
Negative 40 40
Total 6 165 75 170 416
*Species mismatchMalaria Journal 2009, 8:262 http://www.malariajournal.com/content/8/1/262
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and Pv-pLDH lines were related to parasite densities
(HRP-2: V = 0.366, p < 0.001; Pv-pLDH: V = 0.448, p <
0.001), but there was a considerable overlap.
Inter-reader reliability
For the HRP-2 line, the inter-reader reliability for positive
and negative test results was excellent, with 98.0% agree-
ment between the three readers and kappa values between
the different pairs of readers of 0.99, 0.97 and 0.99 respec-
tively. For the Pv-pLDH line, the inter-reader reliability for
positive and negative test results was also excellent, with
98.3% overall agreement and kappa values of 0.97, 0.97
and 0.97 for the different pairs of readers.
In terms of line intensity readings, the overall agreement
for the HRP-2 line was 90.2%, with kappa values of 0.88,
0.91 and 0.88 for the three pairs of readers. For the Pv-
pLDH intensity readings, there was a 91.6% overall agree-
ment with kappa values of 0.80, 0.91 and 0.80 between
the three pairs of readers.
Reproducibility
With regard to line intensity readings, HRP-2 lines were
consistently read upon three times repetition for 14 out of
19 samples. All non-consistent samples had identical test
results upon two times repetition and for a single sample
there was a difference of two categories in line intensity
(weak versus negative). Pv-pLDH intensity readings were
consistent upon three times repetition for 17 out of 19
samples. The two remaining samples had consistent
results upon two times repetition, and one of them had a
single negative result versus two strong line intensity
results. In terms of test results, this meant that two P. fal-
ciparum samples and a single P. vivax sample gave false-
negative results in one out of three test repetitions.
Ease of use
The FK80 was scored as easy to use and the instructions
were scored as clear and simple to perform by all three
technicians. The test was evaluated as practical and the
clearance of the test strip was good. However, the clear-
ance of the test strip was incomplete after the 15 minutes
minimal incubation time recommended by the manufac-
turer. Good clearance was observed only after 20 minutes
of waiting time.
Discussion
The present study evaluated the performance of the FK80
against a panel of whole blood samples from interna-
tional travellers suspected of malaria. The retrospective
design of the study has its limitations. For instance, whole
blood specimens stored at -70°C were used, and the sta-
Table 4: Test characteristics of the FK80 for the detection of P. falciparum related to parasite densities (n = 416)
Species Numbers Correctly identified by 
SDFK80*
Sensitivity in % (95% CI) Specificity in % (95% CI)
All P. falciparum samples 178 163 91.6 (86.2-95.0)
Pure gametocytaemia 22 17 77.3 (54.2-91.3)
Parasite density 0-100/μl 26 23 88.5 (68.7-97.0)
Parasite density 101-1,000/μl 24 22 91.7 (71.5-98.5)
Parasite density >1,000/μl 106 101 95.3 (88.8-98.3)
Parasite density >100/μl 130 123 94.6 (88.8-97.6)
Non-falciparum or no parasites 
seen
238 2** 99.2 (96.7-99.9)
*Unique HRP-2 line visible
**One P. ovale and one P. malariae sample showed a unique HRP-2 line
Table 5: Test characteristics of the FK80 for the detection of P. vivax according to parasite densities (n = 416)
Species Numbers Correctly identified by SDFK80* Sensitivity in %
(95% CI)
Specificity in %
(95% CI)
All P. vivax samples 99 75 75.8 (65.9-83.6)
Parasite density 0-500/μl 31 16 51.6 (33.4-62.4)
Parasite density 501-1,000/μl 9 9 100 (62.9-100)
Parasite density >1,000/μl 59 50 84.7 (72.5-92.4)
Parasite density >500/μl 68 59 86.8 (75.4-93.4)
Non-vivax or no parasites seen 317 0 100 (98.5-100)
*Unique Pv-pLDH line visibleMalaria Journal 2009, 8:262 http://www.malariajournal.com/content/8/1/262
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bility of the target antigens under freezing conditions has
been questioned [11]. However, no obvious differences in
test performance were presently found for samples stored
for several (> 5) years compared to those stored for a
shorter periods (results not shown). In addition, a pro-
spective evaluation of fresh and stored samples revealed
similar results in case of the HRP-2 antigen detection [12].
Another limitation is the fact that a calibrated pipette was
used for the transfer of the blood; with an expected better
accuracy as compared to the kit's application loop. In
addition, the diagnosis and evaluation were carried out in
a reference setting, which makes extrapolation of the
present results to field settings difficult [4,11]. Likewise,
the ease of use was checked by an expert team and not by
untrained end users in remote areas, and it is known that
expert technicians tend to score tests kits more favorably
[13].
The performance of the FK80 can best be compared to
other tests by considering the HRP-2 and Pv-pLDH lines
separately. For the HRP-2 test line in the diagnosis of P.
falciparum, the sensitivities were in line with those
reported in other HRP-2 tests in returned travellers, with
sensitivities ranging from 80% tot 99%, depending on the
setting and parasite densities [2,14-20]. However, the
FK80 did not meet the 95% sensitivity at 100 parasites/μl
as recommended by the WHO [21]. Concerning the diag-
nosis of P. vivax, comparison is more difficult. There are
three reports on the performance of the Pv-pLDH detec-
tion system in the SD FK70 test, a two-band P. vivax RDT
marketed by the same company. Two field studies
reported sensitivities of 96.4% and 93.4% respectively,
with lower values at low parasite densities [22,23]. In
addition, the FK70 was evaluated in the present reference
setting on stored whole blood samples from travellers [6]:
this study demonstrated an overall sensitivity of 88.0%,
with sensitivities at parasite densities below and above
500/μl of 64.3% and 97.2% respectively. Comparison of
the sensitivities of the FK80 Pv-pLDH detection with those
reported for the pan-pLDH target are even more difficult,
as the latter range from 1.5% to 97.0% [24,25]. Compiled
sensitivities for the BinaxNOW® kit for the diagnosis of P.
vivax was reported as 69.6% [25]. With regard to specifi-
city, there was no reaction of any of the P. ovale samples
with the Pv-pLDH test line, but two P. vivax samples gave
positive readings with the HRP-2 line in addition to the
Pv-pLDH line. Of note is the Pv-pLDH positive result in
four P. falciparum samples: in all cases PCR as well as
travel destination argued against P. vivax co-infection, and
three of them occurred at higher parasite densities. This is
in line with earlier observations, in which occasional
cross-reaction of P. falciparum at high parasite densities
was observed in the FK70 [6].
The HRP-2 lines generally were of higher intensities as
compared to the Pv-pLDH lines. The higher line intensi-
ties of the HRP-2 line as compared to the pan-pLDH and
aldolase lines have been described previously [9,26]. For
both the test lines, the line intensities of true positive
results were higher as compared to the previously evalu-
ated FK60 and FK70 tests [6,9].
The intended area of use of the presently evaluated FK80
RDT is confined to regions with both P. falciparum and P.
vivax infections, such as Afghanistan or Korea. In such sit-
uation, the FK80 has an advantage over the traditional
three-band combination RDTs that detect HRP-2 and pan-
species specific pLDH of aldolase: unlike the FK80, their
design does not allow to exclude a mixed infection in the
case of P. falciparum samples that react with both the HRP-
2 and the pan-species lines. The FK80 by virtue of its spe-
cific Pv-pLDH is able to distinguish accurately between
infections caused by P. falciparum, P. vivax and both spe-
cies combined. Accurate diagnosis of P. vivax is important
in view of the need for specific therapy but may also be
interesting because of the study of P. vivax malaria,
because this infection may be serious [27], requires a spe-
cific treatment and is also notorious because of its high
transmissibility [28,29]. In other regions where these two
species co-exist, the presence of P. ovale and P. malariae
can not be excluded and a three-band test with a pan-spe-
cies pLDH will be a better choice. In the setting of travel
medicine, the FK80 may help in distinguishing mixed P.
falciparum  -  P. vivax infections and in the distinction
between P. vivax and P. ovale. However, as in this setting
cost is not a prohibitive factor, a standard three-band RDT
followed by, in case of single pan-pLDH positivity, a two-
band Pv-pLDH RDT such as the FK70 is an alternative to
support the microscopic diagnosis between P. ovale and P.
vivax [6].
In conclusion, the FK80 performed satisfactorily for the
diagnosis of P. falciparum and P. vivax infections in a non-
endemic setting, especially at higher parasite densities.
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